John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LILM
1651
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $1.1M | ﹤0.01% |
+277,279
| New | +$1.28M |
|
1652
First Busey Corp
BUSE
$2.48B
| $1.1M | ﹤0.01% |
43,238
-3,943
| -8% | -$109K |
|
|
AKRO
1653
DELISTED
Akero Therapeutics
AKRO
| $1.09M | ﹤0.01% |
77,060
+57,560
| +295% | +$1.01M |
|
1654
Barnes & Noble Education
BNED
$435M
| $1.09M | ﹤0.01% |
3,052
+1,729
| +131% | +$924K |
|
|
ML
1655
DELISTED
MoneyLion Inc.
ML
| $1.09M | ﹤0.01% |
14,453
| – | – |
|
1656
LCNB Corp
LCNB
$279M
| $1.08M | ﹤0.01% |
61,734
+39,834
| +182% | +$761K |
|
1657
Korn Ferry
KFY
$4.34B
| $1.08M | ﹤0.01% |
+16,599
| New | +$1.12M |
|
1658
Manitowoc
MTW
$705M
| $1.07M | ﹤0.01% |
71,168
+14,769
| +26% | +$254K |
|
1659
Westwater Resources
WWR
$77.1M
| $1.07M | ﹤0.01% |
535,051
+160,779
| +43% | +$326K |
|
|
CATC
1660
DELISTED
CAMBRIDGE BANCORP
CATC
| $1.07M | ﹤0.01% |
12,591
+8,467
| +205% | +$744K |
|
1661
AnaptysBio
ANAB
$1.72B
| $1.07M | ﹤0.01% |
43,211
-43,321
| -50% | -$1.31M |
|
1662
Janus International
JBI
$692M
| $1.07M | ﹤0.01% |
+118,732
| New | +$1.21M |
|
1663
First Internet Bancorp
INBK
$249M
| $1.07M | ﹤0.01% |
24,793
+2,021
| +9% | +$97.8K |
|
1664
Petco
WOOF
$785M
| $1.06M | ﹤0.01% |
+54,422
| New | +$1.02M |
|
|
LEVL
1665
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
| $1.06M | ﹤0.01% |
26,563
+12,765
| +93% | +$521K |
|
1666
Compugen
CGEN
$271M
| $1.06M | ﹤0.01% |
329,279
-78,948
| -19% | -$267K |
|
|
THR
1667
DELISTED
Thermon Group Holdings
THR
| $1.06M | ﹤0.01% |
65,373
-17,300
| -21% | -$301K |
|
1668
Marcus Corp
MCS
$930M
| $1.05M | ﹤0.01% |
59,464
-38,485
| -39% | -$675K |
|
1669
Travel + Leisure Co
TNL
$4.52B
| $1.04M | ﹤0.01% |
18,015
-37,064
| -67% | -$2.09M |
|
|
UHT
1670
Universal Health Realty Income Trust
UHT
$586M
| $1.04M | ﹤0.01% |
17,812
-8,755
| -33% | -$507K |
|
1671
State Street Utilities Select Sector SPDR ETF
XLU
$22.3B
| $1.04M | ﹤0.01% |
27,876
+20,456
| +276% | +$709K |
|
|
GNOG
1672
DELISTED
Golden Nugget Online Gaming, Inc. Class A Common Stock
GNOG
| $1.04M | ﹤0.01% |
145,828
-10,986
| -7% | -$85K |
|
1673
Gorman-Rupp
GRC
$2.04B
| $1.03M | ﹤0.01% |
+28,821
| New | +$1.12M |
|
1674
Miller Industries
MLR
$648M
| $1.03M | ﹤0.01% |
36,647
+26,594
| +265% | +$819K |
|
1675
American Express
AXP
$227B
| $1.03M | ﹤0.01% |
5,500
-368,566
| -99% | -$66.6M |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.